Vivo Ventures V LLC 13D/13G Filings for Soleno Therapeutics, Inc. (SLNO)

Vivo Ventures V LLC 13D and 13G filings for Soleno Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-06-11
5:00 pm
Sale
2020-06-0913DSoleno Therapeutics, Inc.
SLNO
Vivo Ventures V LLC55,742
1.800%
-146,150decrease
(-72.39%)
Filing